Investor results presentation
MedaPhor Group plc (AIM: MED), the intelligent ultrasound software and simulation company, announces it will be reporting its final results for the year ended 31 December 2017 on Wednesday, 21 March 2018.
Investor briefing
Stuart Gall (CEO), Wilson Jennings (FD) and Nicholas Sleep (CTO) will be hosting a briefing for investors on Wednesday, 21 March from 3.30pm to 5pm at the offices of IP Group. There will be an opportunity to see live demonstrations of a number of MedaPhor’s products, including ScanTrainer, HeartWorks and the newly launched BodyWorks simulator platforms, as well as demonstrations of the new ScanNav technology currently under development.
To register to attend for the event and for further details, please contact Walbrook PR on 020 7933 8780 or medaphor@walbrookpr.com.